XML 59 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Parent Company [Member]
   
Cash flows from operating activities:    
Consolidated net income $ 49,100 $ 83,033
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, Amortization and Accretion, Net (12) (20)
Depreciation and amortization 162,099 68,236
Stock compensation expense 2,045 1,171
Proceeds from Stock Options Exercised 9,544 0
Redeemable stock issued 507 377
Amortization of debt premium (14,648) (505)
Gain from investments in real estate joint ventures (2,878) (101)
Loss on Extinguishment of Debt, Including Discontinued Operations 0 169
Derivative interest expense 402 484
Gain on Sale of Derivatives (3,625) 0
Gain on Sale of Non-Depreciable Assets (535) 0
Gain on sale of depreciable assets (6,222) 0
Gain on sale of discontinued operations (5,481) (43,121)
Net casualty loss (gain) and other settlement proceeds 308 (451)
Changes in assets and liabilities:    
Restricted cash 21,318 (279)
Other assets 11,134 (3,176)
Accounts payable 229 5,527
Accrued expenses and other 594 (2,239)
Security deposits 526 277
Net cash provided by operating activities 224,405 109,382
Cash flows from investing activities:    
Purchases of real estate and other assets (166,388) (89,871)
Improvements to existing real estate assets (43,176) (22,494)
Construction Capital and Other Improvements (3,420) (2,137)
Renovations to Existing Real Estate Assets (5,901) (5,112)
Development (29,393) (20,816)
Distributions from real estate joint ventures 11,541 8,197
Contributions to real estate joint ventures 0 (183)
Proceeds from disposition of real estate assets 125,640 73,089
Funding of escrow for future acquisitions (41,640) (11,902)
Net cash used in investing activities (152,737) (71,229)
Cash flows from financing activities:    
Net change in credit lines (181,183) 2,000
Proceeds from Notes Payable 396,180 0
Principal payments on notes payable (230,952) (2,799)
Payment of deferred financing costs (3,395) (426)
Repurchase of common stock (336) (673)
Proceeds from issuances of common shares 575 24,968
Distributions to noncontrolling interests (6,158) (2,391)
Dividends paid on common shares (109,414) (59,115)
Net cash used in financing activities (134,683) (38,436)
Net decrease in cash and cash equivalents (63,015) (283)
Cash and cash equivalents, beginning of period 89,333 9,075
Cash and cash equivalents, end of period 26,318 8,792
Supplemental disclosure of cash flow information:    
Interest paid 75,818 33,610
Income Taxes Paid 803 1,596
Supplemental disclosure of noncash investing and financing activities:    
Conversion of units to shares of common stock 799 444
Accrued construction in progress 8,458 7,126
Interest capitalized 850 872
Marked-to-market adjustment on derivative instruments 1,633 19,916
Fair value adjustment on debt assumed 1,651 704
Notes Assumed 31,692 18,293
Limited Partner [Member]
   
Cash flows from operating activities:    
Consolidated net income 49,100 71,293
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, Amortization and Accretion, Net (12) (20)
Depreciation and amortization 162,099 68,001
Stock compensation expense 2,045 1,171
Proceeds from Stock Options Exercised 9,544 0
Redeemable stock issued 507 377
Amortization of debt premium (14,648) (505)
Gain from investments in real estate joint ventures (2,878) (101)
Loss on Extinguishment of Debt, Including Discontinued Operations 0 169
Derivative interest expense 402 465
Gain on Sale of Derivatives (3,625) 0
Gain on Sale of Non-Depreciable Assets (535) 0
Gain on sale of depreciable assets (6,222) 0
Gain on sale of discontinued operations (5,481) (31,779)
Net casualty loss (gain) and other settlement proceeds 308 (451)
Changes in assets and liabilities:    
Restricted cash 21,318 (278)
Other assets 11,134 (2,076)
Accounts payable 229 5,552
Accrued expenses and other 594 (4,483)
Security deposits 526 296
Net cash provided by operating activities 224,405 107,631
Cash flows from investing activities:    
Purchases of real estate and other assets (166,388) (89,871)
Improvements to existing real estate assets (43,176) (22,383)
Construction Capital and Other Improvements (3,420) (2,137)
Renovations to Existing Real Estate Assets (5,901) (5,112)
Development (29,393) (20,816)
Distributions from real estate joint ventures 11,541 8,197
Contributions to real estate joint ventures 0 (183)
Proceeds from disposition of real estate assets 125,640 56,386
Funding of escrow for future acquisitions (41,640) (11,902)
Net cash used in investing activities (152,737) (87,821)
Cash flows from financing activities:    
Advances from General Partner 0 18,021
Net change in credit lines (181,183) 2,000
Proceeds from Notes Payable 396,180 0
Principal payments on notes payable (230,952) (2,799)
Payment of deferred financing costs (3,395) (426)
Payments for Repurchase of Common Units (336) (673)
Proceeds from Issuance of Common Limited Partners Units 575 24,969
Distributions Paid on Common Units (115,572) (61,044)
Net cash used in financing activities (134,683) (19,952)
Net decrease in cash and cash equivalents (63,015) (142)
Cash and cash equivalents, beginning of period 89,333 8,934
Cash and cash equivalents, end of period 26,318 8,792
Supplemental disclosure of cash flow information:    
Interest paid 75,818 33,610
Income Taxes Paid 803 1,596
Supplemental disclosure of noncash investing and financing activities:    
Accrued construction in progress 8,458 7,126
Interest capitalized 850 872
Marked-to-market adjustment on derivative instruments 1,633 19,916
Fair value adjustment on debt assumed 1,651 704
Notes Assumed $ 31,692 $ 18,293